Since it is already happening on the face of it and LG adopts similar tactics that prevent responsibility or reaction by proxyfing to trolls. This is the kind of things OIN was supposed to protect but we have seen hardly any evidence that OIN is taking any effective measures to protect against them. "With [...]
IBM is one of the dominant forces in all of the computerdom and technology in general, has slipped down a little. People argue that the company is fading, here are some of the indicators of IBM are fading: The company gave up the PC business, perhaps wisely, but never made up for it with [...]
Waymo is an autonomous car development company spun out of Google's parent company, Alphabet Inc., in December 2016. It then took over the self-driving car project which Google had begun in 2009. Alphabet describes Waymo as “a self-driving tech company with a mission to make it safe and easy for people and things to move around.” The new company, [...]
International group representing doctors and patient have launched a fresh challenge to the patent on Gilead Sciences’ hepatitis C drug Sofosbuvir at the European patent office in order to increase access to treatment. Sofosbuvir is sold by the US drugmaker as Sovaldi and is included in other hepatitis C medicine such as Harvoni and [...]
Supreme Court will hear argument in TC Heartland v. Kraft Foods. This critically important case involves the meaning of the patent venue statute and where plaintiffs who claim infringement may bring suit. Fighting over where cases can be brought may sound like the sort of thing only lawyers would care about, but I assure you, this [...]
The European Patent Office (EPO) announced on 23 March its “intention to grant a patent” to the University of California (UC) for its broad-based claims about the genome-editing tool popularly known as CRISPR. UC, on behalf of several parties, has been in a pitched battle with the Broad Institute of Cambridge, Massachusetts, over CRISPR [...]
